Pulikang Secures Tens of Millions of RMB in Series B Funding from Honghui Capital to Expand Third-Party Medical Sterilization Services
VCBeat (WeChat ID: vcbeat) has learned that Shanghai Julikang Investment Co., Ltd. (hereinafter referred to as “Julikang”) announced the recent completion of its Series B financing round, amounting to tens of millions of yuan, with Honghui Capital as the investor. The proceeds from this round will be primarily used for the construction of new medical sterilization supply centers, the upgrading and renovation of existing centers, and the enhancement of the traceability software and information systems.
Julikang, established in 2010, is a healthcare service provider specializing in independent third-party sterile supply services. It is committed to consistently delivering safe, efficient, and trustworthy medical disinfection and sterilization services to healthcare institutions.
Headquartered in Shanghai, the company has been specializing in medical sterilization supply services for nearly a decade. It has established independent third-party medical sterilization supply centers in multiple provinces and municipalities, including Shanghai, Tianjin, Guangzhou, Anhui, Fujian, Shaanxi, Chongqing, Liaoning, and Henan. The company serves hundreds of healthcare institutions of various types—such as general hospitals, orthopedic hospitals, ophthalmic hospitals, thoracic hospitals, oncology hospitals, obstetrics and gynecology hospitals, and community hospitals—as well as providing sterilization services for consigned surgical instruments.
The Julikang team possesses extensive experience in the design, production and supply, quality control, logistics, and software development of sterile supply centers. Its services have earned the trust of hospitals and high praise from infection control specialists, thereby driving the development of third-party medical sterile supply centers in China.
The provision of multi-level and diversified medical services by non-governmental entities represents a significant step toward modernizing China’s healthcare governance system and capabilities. Third-party sterile supply centers can help hospitals save on medical facility space, reduce healthcare costs, minimize redundant investment in medical resources, and enhance the regional standard of sterile supply services. These centers demonstrate substantial social and economic benefits, align with national healthcare reform policies, and represent an inevitable future trend.
Safety, stability, efficiency, specialization, and scalability are the core competencies of the third-party medical sterile supply industry. With nearly a decade of deep engagement in this sector, Julikang has independently developed information systems, standard operating procedures, and quality control frameworks tailored for third-party providers. Having earned recognition and trust from numerous renowned Grade A tertiary hospitals, Julikang has accumulated comprehensive expertise. Its standardized, systematic, and professional approach has established it as a well-known brand and a leading enterprise in the third-party sterile supply industry.
Over the past year, Julikang has completed the upgrading and renovation of centers established prior to the implementation of new regulations, as well as the application for Medical Institution Practice Licenses. It has successfully built three new centers and designed and constructed its first intelligent sterile supply center.
Regarding the successful completion of this financing round, Shen Jiayin, Founder and Chairman of Julikang, stated: “For nearly a decade, Julikang has been dedicated to the field of medical sterile supply services. We have always remained vigilant about medical safety, continuously enhanced our professional expertise, and improved our service capabilities. Looking back on our journey, we would like to express our gratitude in three aspects: First, we thank the hospitals for their trust and the experts for their guidance; second, we thank our clients for their high expectations and stringent standards, which have strengthened our team; and finally, we thank Honghui Capital for recognizing Julikang’s philosophy of ‘focusing on customer service, safeguarding patient health, and adhering to professional development,’ as well as the incremental achievements made through our team’s unremitting efforts over the past ten years. The proceeds from this financing will be used for the construction of new centers and the upgrading and renovation of existing ones, enabling Julikang to serve more customers with higher-quality services. We believe that by working hand in hand with Honghui Capital in the development of third-party sterile supply centers, we will make even greater contributions to third-party services for healthcare institutions.”
Regarding the successful investment in Julikang, Wu Jin, Partner at HighLight Capital, stated: “Julikang has accumulated extensive experience in the third-party sterile supply center chain industry, truly helping hospitals reduce costs and improve efficiency so that they can focus more on their core medical services. Companies with such long-term value have always been respected by our fund. Furthermore, the company’s team is highly professional, strongly mission-driven, and places utmost importance on operational safety. We hope this financing will help the company continue to expand its chain scale, sharing the critical responsibility of sterile supply with more healthcare institutions through consistent professional services.”
In the future, Julikang will focus on continuously enhancing its medical sterilization and supply services, improving quality control management standards, and steadily advancing the construction of new centers in line with its development trajectory. The company aims to establish each center as a premium facility, delivering refined and specialized services to hospitals.
Related Reading: